arginyl-glycyl-aspartic acid has been researched along with Kaposi Sarcoma in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ai, H; Boothman, DA; Gao, J; Nasongkla, N; Pink, J; Shuai, X; Weinberg, BD | 1 |
Chandran, B; Fingeroth, J; Groopman, JE; Persaud, K; Pytowski, B; Wang, JF; Zhang, X | 1 |
Bacigalupo, I; Barillari, G; Cereseto, A; Chiozzini, C; Ensoli, B; Falchi, M; Mainiero, F; Nappi, F; Sgadari, C; Strippoli, R; Toschi, E | 1 |
Barillari, G; Ensoli, B; Gallo, RC; Gendelman, R | 1 |
Ganju, RK; Gill, P; Groopman, JE; Liu, ZY; Munshi, N; Nair, BC | 1 |
Barillari, G; Cafaro, A; Colombini, S; Ensoli, B; Fiorelli, V; Manzari, V; Modesti, A; Nair, BC; Samaniego, F; Sgadari, C; Stürzl, M | 1 |
Barillari, G; Caputo, A; Ensoli, B; Gendelman, R; Markham, P; Morris, CB; Nair, BC; Nel, A; Palladino, C; Sgadari, C; Stürzl, M | 1 |
7 other study(ies) available for arginyl-glycyl-aspartic acid and Kaposi Sarcoma
Article | Year |
---|---|
cRGD-functionalized polymer micelles for targeted doxorubicin delivery.
Topics: Biopolymers; Cell Line, Tumor; Cyclization; Doxorubicin; Drug Delivery Systems; Humans; Magnetic Resonance Spectroscopy; Micelles; Microscopy, Atomic Force; Molecular Structure; Oligopeptides; Sarcoma, Kaposi | 2004 |
Kaposi's sarcoma-associated herpesvirus activation of vascular endothelial growth factor receptor 3 alters endothelial function and enhances infection.
Topics: Amino Acid Motifs; Binding, Competitive; Blotting, Western; Cell Line; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Cytokines; DNA; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Heparin; Herpesvirus 8, Human; Humans; Immunoprecipitation; Integrin alpha3beta1; Ligands; Microcirculation; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; Oligopeptides; Open Reading Frames; Plasmids; Polymerase Chain Reaction; Protein Binding; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proteoglycans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma, Kaposi; Signal Transduction; Skin Neoplasms; Time Factors; Transfection; Vascular Endothelial Growth Factor Receptor-3; Viral Envelope Proteins | 2005 |
HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway.
Topics: Adaptor Proteins, Signal Transducing; Cell Cycle; Cell Proliferation; Cells, Cultured; Endothelial Cells; Enzyme Activation; Gene Products, tat; GRB2 Adaptor Protein; HIV-1; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oligopeptides; Phosphorylation; ras Proteins; Sarcoma, Kaposi; Shc Signaling Adaptor Proteins; Signal Transduction; Src Homology 2 Domain-Containing, Transforming Protein 1; tat Gene Products, Human Immunodeficiency Virus | 2006 |
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.
Topics: Acquired Immunodeficiency Syndrome; Amino Acid Sequence; Antibodies; Cell Adhesion; Cells, Cultured; Culture Media, Conditioned; Endothelium, Vascular; Gene Products, tat; HIV-1; Humans; Integrins; Lymphocyte Activation; Molecular Sequence Data; Muscle, Smooth, Vascular; Oligopeptides; Peptide Fragments; Receptors, Cytoadhesin; Receptors, Fibronectin; Receptors, Vitronectin; Recombinant Proteins; Sarcoma, Kaposi; T-Lymphocytes; tat Gene Products, Human Immunodeficiency Virus | 1993 |
Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells.
Topics: Calcium-Calmodulin-Dependent Protein Kinases; Crk-Associated Substrate Protein; Cytoskeletal Proteins; Focal Adhesion Kinase 2; Gene Products, tat; HIV-1; Humans; Oligopeptides; Paxillin; Phosphoproteins; Phosphorylation; Protein-Tyrosine Kinases; Proteins; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Retinoblastoma-Like Protein p130; Sarcoma, Kaposi; tat Gene Products, Human Immunodeficiency Virus; Tumor Cells, Cultured; Tyrosine | 1998 |
The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor.
Topics: Binding, Competitive; Cell Adhesion; Cell Division; Cell Movement; Cytokines; Endothelium, Vascular; Extracellular Matrix Proteins; Fibroblast Growth Factor 2; Gene Products, tat; Genes, tat; Heparan Sulfate Proteoglycans; HIV-1; Humans; Macromolecular Substances; Molecular Mimicry; Neovascularization, Pathologic; Oligopeptides; Peptide Fragments; Protein Conformation; Receptors, Fibronectin; Receptors, Vitronectin; Recombinant Proteins; Sarcoma, Kaposi; Skin Neoplasms; Solubility; tat Gene Products, Human Immunodeficiency Virus | 1999 |
Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
Topics: Animals; Antigens, CD; Cell Adhesion; Cell Division; Cell Line; Cell Movement; Cytokines; Drug Synergism; Endothelial Growth Factors; Endothelium, Vascular; Fibroblast Growth Factor 2; Gene Products, tat; HIV-1; Humans; Injections, Subcutaneous; Integrin beta Chains; Integrin beta3; Integrins; Lymphokines; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Physiologic; Oligopeptides; Platelet Membrane Glycoproteins; Receptors, Vitronectin; Sarcoma, Kaposi; tat Gene Products, Human Immunodeficiency Virus; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |